Physiological concentrations of retinoic acid favor myeloid dendritic cell development over granulocyte development in cultures of bone marrow cells from mice.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of NutriLife

• Publication date

  2004-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JN/134.10.2653PMID 15465762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• All‐trans retinoic acid skews monocyte differentiationinto interleukin‐12‐secreting dendritic‐like cells

  2003cited by this paper
• Dendritic cell precursor populations of mouse blood: identification of the murine homologues of human blood plasmacytoid pre-DC2 and CD11c+ DC1 precursors.

  2003cited by this paper
• All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.

  2003cited by this paper
• Role of neutrophils in the synergistic liver injury from monocrotaline and bacterial lipopolysaccharide exposure.

  2003cited by this paper
• Retinoic acid receptor antagonism in vivo expands the numbers of precursor cells during granulopoiesis

  2002cited by this paper
• Characterization of a common precursor population for dendritic cells

  2002cited by this paper
• Retinoic acid enhances the T helper 2 cell development that is essential for robust antibody responses through its action on antigen-presenting cells.

  2002cited by this paper
• The cytokines IL-3 and GM-CSF regulate the transcriptional activity of retinoic acid receptors in different in vitro models of myeloid differentiation.

  2002cited by this paper
• The role of retinoids and retinoic acid receptors in normal hematopoiesis

  2002cited by this paper
• Mouse and human dendritic cell subtypes

  2002cited by this paper
• Vitamin A, infection and immune function.

  2002influential reference
• A Common Pathway for Dendritic Cell and Early B Cell Development

  2001cited by this paper
• Lineage restriction of the RARα gene expression in myeloid differentiation

  2001cited by this paper
• Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1

  2001cited by this paper
• Lineage restriction of the RARalpha gene expression in myeloid differentiation.

  2001cited by this paper
• Vitamin A, infection, and immune function.

  2001cited by this paper
• CD8− Dendritic Cell Activation Status Plays an Integral Role in Influencing Th2 Response Development1

  2001cited by this paper
• Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells1

  2001cited by this paper
• Development of CD8α-Positive Dendritic Cells from a Common Myeloid Progenitor

  2000cited by this paper
• Vitamin A deficiency in mice causes a systemic expansion of myeloid cells

  2000cited by this paper
• Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.

  2000cited by this paper
• Vitamin A deficiency in mice causes a systemic expansion of myeloid cells.

  2000cited by this paper
• Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures.

  2000cited by this paper
• Development of CD8alpha-positive dendritic cells from a common myeloid progenitor.

  2000cited by this paper
• Immunobiology of dendritic cells.

  2000cited by this paper
• Distinct dendritic cell subsets differentially regulate the class of immune response in vivo.

  1999cited by this paper
• Isolation of Dendritic Cells

  1998cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• Retinoic acid repletion restores the number of leukocytes and their subsets and stimulates natural cytotoxicity in vitamin A-deficient rats.

  1995cited by this paper
• Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen

  1994cited by this paper
• Vitamin A, immunity, and infection.

  1994cited by this paper
• In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function.

  1994cited by this paper
• Aberrant T-cell function in vitro and impaired T-cell dependent antibody response in vivo in vitamin A-deficient rats.

  1993cited by this paper
• Antibody production in vitamin A‐depleted rats is impaired after immunization with bacterial polysaccharide or protein antigens

  1990cited by this paper
• Characterization of a helper T lymphocyte defect in vitamin A-deficient mice.

  1989cited by this paper
• The effect of retinoids on dendritic cell function.

  1989cited by this paper
• The effect of retinoids on dendritic cell function.

  1989cited by this paper
• Regulation of accessory cell function by retinoids in murine immune responses.

  1987cited by this paper
• Contrasting impairments in IgM and IgG responses of vitamin A-deficient mice.

  1987cited by this paper
• Impaired immunity in vitamin A-deficient mice.

  1987cited by this paper

• Towards the development of next-generation lung cancer immunotherapy

  2025cites this paper
• Ruxolitinib and oHSV combination therapy increases CD4 T cell activity and germinal center B cell populations in murine sarcoma

  2024cites this paper
• Myeloid-derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review)

  2024cites this paper
• Role played by MDSC in colitis-associated colorectal cancer and potential therapeutic strategies

  2024cites this paper
• Sulforaphane activates CD8+ T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis’

  2024cites this paper
• A new approach to overcoming resistance to immunotherapy: nanotechnology

  2023cites this paper
• Glycolysis inhibition ameliorates brain injury after ischemic stroke by promoting the function of myeloid-derived suppressor cells.

  2022cites this paper
• Immune Modulation by Myeloid-Derived Suppressor Cells in Diabetic Kidney Disease

  2022cites this paper
• Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets

  2022cites this paper
• Roles of the Exosomes Derived From Myeloid-Derived Suppressor Cells in Tumor Immunity and Cancer Progression

  2022cites this paper
• The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment

  2020cites this paper
• Nanoparticle mediated cancer immunotherapy.

  2020cites this paper
• Initial Mechanistic Screening of Transamniotic Stem Cell Therapy in the Rodent Model of Spina Bifida: Host Bone Marrow and Paracrine Activity

  2020cites this paper
• Nuclear hormone receptors and lipid antigen presentation in dendritic cells

  2019cites this paper
• MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation

  2019cites this paper
• Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma

  2019cites this paper
• Treatment of Metastatic or High-Risk Solid Cancer Patients by Targeting the Immune System and/or Tumor Burden: Six Cases Reports

  2019cites this paper
• Vitamin A Metabolism by Dendritic Cells Triggers an Antimicrobial Response against Mycobacterium tuberculosis

  2019cites this paper
• Role of Vitamin A in Modulating Graft-versus-Host Disease

  2018cites this paper
• Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer

  2018cites this paper
• TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy

  2018cites this paper
• 9‐cis‐Retinoic acid induces a distinct regulatory dendritic cell phenotype that modulates murine delayed‐type allergy

  2018cites this paper
• Nanomaterials for cancer immunotherapy.

  2017cites this paper
• Myeloid-Derived Suppressor Cells

  2017cites this paper
• The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy

  2017influential citation
• Targeting Myeloid-Derived Suppressor Cells in Cancer.

  2017cites this paper
• Myeloid‐derived suppressor cells—a new therapeutic target to overcome resistance to cancer immunotherapy

  2017influential citation
• MIF-Dependent Regulation of Monocyte/Macrophage Polarization

  2017cites this paper
• The Role of Myeloid-Derived Suppressor Cells in Viral Infection

  2017influential citation
• Nanotechnology based therapeutic modality to boost anti‐tumor immunity and collapse tumor defense

  2017cites this paper
• The immunobiology of myeloid-derived suppressor cells in cancer

  2016cites this paper
• Decreased RARβ expression induces abundant inflammation and cervical precancerous lesions.

  2016cites this paper
• MDSC: Myeloid-Derived Suppressor Cells

  2016cites this paper
• Vitamin A induction in reactive oxigen intermediate and nitric oxide intermediate production against Plasmodium berghei

  2015cites this paper
• 6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells

  2015cites this paper
• Multicystic dedifferentiated retroperitoneal liposarcoma: tumour cyst fluid analysis and implications for management

  2015cites this paper
• Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis.

  2015cites this paper
• Опухолевое микроокружение как мишень терапии злокачественных глиом Tumor microenvironment as a target of malignant gliomas

  2015cites this paper
• The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.

  2014cites this paper
• Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages

  2014cites this paper
• General introduction: targeting myeloid suppression in cancer immunotherapy

  2014cites this paper
• Carotenoids, inflammation, and oxidative stress--implications of cellular signaling pathways and relation to chronic disease prevention.

  2014cites this paper
• Continuous retinoic acid induces the differentiation of mature regulatory monocytes but fails to induce regulatory dendritic cells

  2014cites this paper
• Stromal-dependent tumor promotion by MIF family members.

  2014cites this paper
• The role of immune-related myeloid cells in angiogenesis.

  2013cites this paper
• All‐trans retinoic acid protects hepatocellular carcinoma cells against serum‐starvation‐induced cell death by upregulating collagen 8A2

  2013cites this paper
• Host and Microbial Factors in Regulation of T Cells in the Intestine

  2013cites this paper
• Rôles des cellules myéloïdes suppressives et des infiltrats immunitaires dans le cancer

  2013cites this paper
• Review on role of Myeloid-derived Suppressor cells in regulation of immune system

  2013cites this paper
• Retinoic Acid Signaling in Hematopoiesis and Immune Functions, and Options for Chemoprevention

  2013cites this paper
• Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer

  2013cites this paper
• Tumor–stromal interactions in lung cancer: novel candidate targets for therapeutic intervention

  2012cites this paper
• Oral vitamin A and retinoic acid supplementation stimulates antibody production and splenic Stra6 expression in tetanus toxoid-immunized mice.

  2012cites this paper
• Myeloid Derived Suppressor Cells: Subsets, Expansion, and Role in Cancer Progression

  2012cites this paper
• Retinoic acid receptor β deficiency reduces splenic dendritic cell population in a conditional mouse line.

  2012cites this paper
• Retinoic acid, immunity, and inflammation.

  2011cites this paper
• Cross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunity.

  2011cites this paper
• Retinoic acid production by intestinal dendritic cells.

  2011cites this paper
• Effect of retinoic acid receptor β (RARβ) deficiency on DC in a conditional mouse line

  2011cites this paper
• Vitamin A deficiency alters splenic dendritic cell subsets and increases CD8(+)Gr-1(+) memory T lymphocytes in C57BL/6J mice.

  2010influential citation
• Vitamin A upregulates matrix metalloproteinase-9 activity by murine myeloid dendritic cells through a nonclassical transcriptional mechanism.

  2010cites this paper
• Myeloid-Derived Suppressor Cells in Human Cancer

  2010cites this paper
• Prolonged disease control after myeloablative chemotherapy, autologous transplantation and immunotherapy in high-risk early breast cancer.

  2010cites this paper
• Retinoids as critical modulators of immune functions: new therapeutic perspectives for old compounds.

  2009cites this paper
• Myeloid-derived suppressor cells as regulators of the immune system

  2009cites this paper
• Beta-interferon, retinoids and tamoxifen in metastatic breast cancer: long-term follow-up of a phase II study.

  2009cites this paper
• Probiotic preparation VSL#3 alters the distribution and phenotypes of dendritic cells within the intestinal mucosa in C57BL/10J mice.

  2009cites this paper
• Physiology and therapeutics of vascular endothelial growth factor in tumor immunosuppression.

  2009cites this paper
• The identification and enumeration of dendritic cell populations from individual mouse spleen and Peyer's patches using flow cytometric analysis

  2009cites this paper
• Retinoic acid inhibits dendritic cell differentiation driven by interleukin-4.

  2009cites this paper
• Immunotherapy in patients with less than complete response to chemotherapy.

  2009cites this paper
• Augmentation of antibody responses by retinoic acid and costimulatory molecules.

  2009cites this paper
• Maintenance immunotherapy in metastatic breast cancer.

  2008cites this paper
• Retinoic acid decreases adherence of murine myeloid dendritic cells and increases production of matrix metalloproteinase-9.

  2008influential citation
• Multicenter phase II study of chemoimmunotherapy in the treatment of metastatic melanoma

  2008cites this paper
• Myeloid-derived suppressor cells.

  2007cites this paper
• Vitamin A supplementation and retinoic acid treatment in the regulation of antibody responses in vivo.

  2007cites this paper
• Multicenter Phase II Study of Chemo-immunotherapy in the Treatment of Metastatic Renal Cell Carcinoma

  2007cites this paper
• Chemoimmunotherapy in the treatment of metastatic gastric cancer

  2007cites this paper
• Phase II study of interleukin-2 and 13-cis-retinoic acid as maintenance therapy in metastatic colorectal cancer

  2007cites this paper
• Role Of Immature Myeloid Cells in Mechanisms of Immune Evasion In Cancer

  2006cites this paper
• All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.

  2006cites this paper
• Retinoic Acid and Polyriboinosinic:Polyribocytidylic Acid Stimulate Robust Anti-Tetanus Antibody Production while Differentially Regulating Type 1/Type 2 Cytokines and Lymphocyte Populations1

  2005cites this paper
• ALL-TRANS RETINOIC ACID COMBINED WITH POLYRIBOINOSINIC:POLYRIBOCYTIDYLIC ACID PROMOTES TETANUS TOXOID-INDUCED VACCINE RESPONSES IN ADULT AND NEONATAL MICE

  2005cites this paper
• Populations Type 1 / Type 2 Cytokines and Lymphocyte Production while Differentially Regulating Stimulate Robust Anti-Tetanus Antibody Polyriboinosinic : Polyribocytidylic Acid Retinoic Acid and

  2005cites this paper
• Regulation of hematopoiesis by retinoid signaling.

  2005cites this paper
• Nutrition and physiological function

  2003cites this paper
• General Discussion

  1968cites this paper
• Digital Commons

  year unknowncites this paper